Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Antibodies | 4 | 2025 | 57 | 0.710 |
Why?
|
| HIV-1 | 5 | 2025 | 836 | 0.590 |
Why?
|
| HIV Envelope Protein gp41 | 4 | 2025 | 9 | 0.480 |
Why?
|
| Antibodies, Neutralizing | 4 | 2025 | 265 | 0.440 |
Why?
|
| HIV Infections | 5 | 2025 | 2720 | 0.320 |
Why?
|
| Receptors, IgG | 3 | 2025 | 74 | 0.290 |
Why?
|
| Receptors, CCR5 | 1 | 2025 | 57 | 0.240 |
Why?
|
| Saponins | 1 | 2024 | 8 | 0.230 |
Why?
|
| Antibodies, Bispecific | 1 | 2025 | 49 | 0.230 |
Why?
|
| Adjuvants, Immunologic | 1 | 2024 | 221 | 0.210 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2025 | 381 | 0.190 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2021 | 17 | 0.180 |
Why?
|
| Nanoparticles | 1 | 2024 | 374 | 0.170 |
Why?
|
| B-Lymphocytes | 1 | 2025 | 815 | 0.160 |
Why?
|
| Cell Surface Display Techniques | 1 | 2017 | 11 | 0.140 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 601 | 0.140 |
Why?
|
| Enzyme Assays | 1 | 2017 | 25 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 1367 | 0.130 |
Why?
|
| Cystine-Knot Miniproteins | 1 | 2016 | 1 | 0.130 |
Why?
|
| Cell Adhesion Molecules | 1 | 2017 | 173 | 0.130 |
Why?
|
| Thebaine | 1 | 2015 | 1 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2016 | 105 | 0.120 |
Why?
|
| Hydrocodone | 1 | 2015 | 16 | 0.120 |
Why?
|
| Integrins | 1 | 2016 | 94 | 0.120 |
Why?
|
| Genetic Engineering | 1 | 2015 | 88 | 0.120 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 754 | 0.120 |
Why?
|
| Immunoconjugates | 1 | 2016 | 103 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 643 | 0.110 |
Why?
|
| Oligopeptides | 1 | 2016 | 257 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2017 | 385 | 0.110 |
Why?
|
| Neoplasms | 2 | 2016 | 2470 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2015 | 532 | 0.090 |
Why?
|
| HEK293 Cells | 2 | 2025 | 697 | 0.090 |
Why?
|
| Animals | 7 | 2025 | 35360 | 0.070 |
Why?
|
| Mice | 4 | 2025 | 16937 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2061 | 0.060 |
Why?
|
| Neutralization Tests | 1 | 2025 | 73 | 0.060 |
Why?
|
| CD4 Antigens | 1 | 2025 | 138 | 0.060 |
Why?
|
| Gene Knockout Techniques | 1 | 2025 | 109 | 0.060 |
Why?
|
| AIDS Vaccines | 1 | 2024 | 47 | 0.060 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 109 | 0.050 |
Why?
|
| Viral Load | 1 | 2025 | 448 | 0.050 |
Why?
|
| Membrane Lipids | 1 | 2022 | 91 | 0.050 |
Why?
|
| Immune Sera | 1 | 2021 | 86 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2021 | 47 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 2021 | 59 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2021 | 157 | 0.040 |
Why?
|
| Protein Binding | 2 | 2017 | 2121 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2021 | 119 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 253 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2025 | 573 | 0.040 |
Why?
|
| Humans | 8 | 2025 | 129622 | 0.040 |
Why?
|
| Immunization | 1 | 2021 | 411 | 0.040 |
Why?
|
| Aminoacyltransferases | 1 | 2017 | 3 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 68 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2058 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 847 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2016 | 48 | 0.030 |
Why?
|
| Cytokines | 1 | 2024 | 2017 | 0.030 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2016 | 39 | 0.030 |
Why?
|
| Papaver | 1 | 2015 | 1 | 0.030 |
Why?
|
| Benzylisoquinolines | 1 | 2015 | 1 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 156 | 0.030 |
Why?
|
| Morphinans | 1 | 2015 | 8 | 0.030 |
Why?
|
| Codeine | 1 | 2015 | 5 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2015 | 24 | 0.030 |
Why?
|
| Cell Line | 1 | 2021 | 2781 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 385 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 62 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 390 | 0.030 |
Why?
|
| Biological Products | 1 | 2016 | 202 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 814 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 336 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 1086 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 1492 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 835 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 942 | 0.020 |
Why?
|
| Peptides | 1 | 2016 | 925 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3215 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2391 | 0.020 |
Why?
|
| Male | 1 | 2025 | 63674 | 0.010 |
Why?
|